SZSE Releases
Companies
Releases
Pricing
Home
/
Companies
/
Jiangxi Fushine Pharmaceutical Co., Ltd.
/
Release
300497
SZSE
Report on the Evaluation of the Performance of the Accounting Firm for 2025 by the Audit Committee of the Board of Directors
Jiangxi Fushine Pharmaceutical Co., Ltd.
·
April 27, 2026
Full Translation